SCHEMBL2803145

SCHEMBL2803145

CN(C)S(=O)(=O)NC(=O)c1cnn2c(NCc3ccccc3)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT6 P42226 1/20 0.38
ENPP2 Q13822 1/20 0.38
SPR P35270 3/20 0.38
THRB P10828 2/20 0.37
LMNA P02545 1/20 0.36
HCRTR2 O43614 1/20 0.36
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TPSAB1 Q15661 2/20 0.35
MGLL Q99685 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
AXL P30530 1/20 0.35
FLT3 P36888 1/20 0.35
TYRO3 Q06418 1/20 0.35
MERTK Q12866 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799687 0.93 STAT6 (0.40) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2804072 0.91 STAT6 (0.41) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2802824 0.91 STAT6 (0.39) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2801068 0.90 RBP4 (0.39) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2805767 0.90 RBP4 (0.37) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2799699 0.90 SPR (0.38) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2802391 0.88 SMN1; SMN2 (0.41) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2800008 0.88 TPSAB1 (0.38) STAT6ENPP2SPRTHRBLMNA
SCHEMBL2800864 0.88 CCR1 (0.42) STAT6ENPP2THRBSMN1; SMN2
SCHEMBL2802693 0.88 TP53 (0.41) STAT6ENPP2LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 STAT6 146/4885ENPP2 1017/4885SPR 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.